Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy

Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):302-310. doi: 10.1093/ehjcvp/pvab048.
No abstract available

Keywords: Cardiovascular pharmacotherapy; Randomized clinical trials; Subgroup analyses.

Publication types

  • Review

MeSH terms

  • Cardiovascular System*
  • Humans
  • Randomized Controlled Trials as Topic